IRINOTECAN Accord 300 mg/15 ml conc perf 1 pce
7680667660033
CH-66766
L01CE02
07.16.1.
Active substances:
1 / 3
google
Details
- Product number
- 6676603
- CPT
- -
- Packaging group
- 1
- Unit
- Durchstechflasche(n)
- Composition
- irinotecani hydrochloridum trihydricum 300 mg, acidum lacticum, sorbitolum 675 mg, natrii hydroxidum, acidum hydrochloridum, aqua ad iniectabile q.s. ad solutionem pro 15 ml corresp. natrium max. 1.21 mg.
Articles (1)
Irinotecan Accord 300 mg/15 ml, Konzentrat zur Herstellung einer Infusionslösung
Konzentrat
1
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
irinotecani hydrochloridum trihydricum
|
300.0 MG | Substance | Wirkstoff (Principe actif) |
|
acidum lacticum
|
- | Substance | HNIDK |
|
sorbitolum
|
675.0 MG | Substance | HBESI |
|
natrii hydroxidum
|
- | Substance | HNIDK |
|
acidum hydrochloridum
|
- | Substance | HNIDK |
|
aqua ad iniectabile
|
- | Substance | HNIDK |
|
natrium
|
- | Substance | HBESI |
Reimbursement information
Public price
CHF 283.55
Specialties list
Yes
Generic
Yes
SL addition date:
01/12/2018
Authorization holder
Accord Healthcare AG
4103 Bottmingen
Authorization information
- Swissmedic authorization number
- 66766
- Drug name
- Irinotecan Accord, Konzentrat zur Herstellung einer Infusionslösung
- Galenic form
- KOINF
- ATC Code
- L01CE02
- Authorization status
- Z
- Dispensation category
- A
- First authorization
- 24/09/2018
- Authorization expiration date
- 31/12/9999
- IT number
- 07.16.1.
- Domain
- Human medicine
Packaging details
- Description (FR)
- IRINOTECAN Accord 300 mg/15 ml conc perf 1 pce
- Description (DE)
- IRINOTECAN Accord 300 mg/15 ml Konz Inf 1 Stk
- Market launch
- 24/09/2018
- Narcotic (BTM)
- No